1. Medtech Insight

German Medtechs Search For Blue Skies Amid ‘Cloudy Outlook’ For Industry − Medica 2023

Regulatory compliance is no longer the only pressing issue for medtechs in Germany

 
• By Ashley Yeo

While revenues are looking healthier at last, a host of issues in the post-COVID readjustment phase still weigh heavily on medtech manufacturers in Germany, chief among which is EU and national over-regulation. Hospital reform and the digital shift are also on a long list of priority issues to monitor and tackle if Germany’s industrial base is to remain preeminent, said BVMed chief executive Marc-Pierre Möll.

Storm clouds gather over the sea near castletownbere in county cork, republic of ireland, shot in october 2016. taken from the shore near the town beach. - Image

Marc-Pierre Möll joined German medtech industry association BVMed almost five years ago as chief executive. That was shortly after the Medical Device (2017/745) and IVD Regulation (2017/746) were implemented. They unleashed a thirst for information, support and advice in an industry sent reeling by an explosion of new regulatory requirements and costs, and confusion over precisely how to comply.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Germany

More from Europe